🔎 Trials Near Me

Home › B-Cell Lymphoma › Georgia

Pag-aaral pangklinika para sa B-Cell Lymphoma sa Georgia

8 pag-aaral para sa B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa Georgia.

Mga Lungsod sa Georgia

Opisyal na teksto ng pag-aaral (English)

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

  • Central Georgia Cancer Care, Macon
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07516093

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Augusta University Medical Center, Augusta
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • Winship Cancer Institute of Emory University, Atlanta
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Northside Hospital, Atlanta
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

  • Winship Cancer Institute of Emory University, Atlanta
  • Georgia Cancer Center at Augusta University, Augusta
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

SynKIR-310 for Relapsed/Refractory B-NHL

  • Winship Cancer Institute of Emory University, Atlanta
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT06544265

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Healthcare of Atlanta, Emory University, Atlanta
Nagre-recruitPhase 1
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.